About CVS Health Corporation
https://www.cvshealth.comCVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
CEO
J. David Joyner CEBS
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2005-06-07 | Forward | 2:1 |
| 1998-06-16 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 775
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
Grade Summary
Showing Top 6 of 16
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:119.84M
Value:$9.51B
VANGUARD GROUP INC
Shares:118.89M
Value:$9.43B
BLACKROCK INC.
Shares:100.15M
Value:$7.94B
Summary
Showing Top 3 of 2,673
About CVS Health Corporation
https://www.cvshealth.comCVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $102.87B ▲ | $17.01B ▲ | $-3.98B ▼ | -3.86% ▼ | $-3.13 ▼ | $-1.56B ▼ |
| Q2-2025 | $98.92B ▲ | $11.21B ▲ | $1.02B ▼ | 1.03% ▼ | $0.81 ▼ | $3.58B ▼ |
| Q1-2025 | $94.59B ▼ | $11.02B ▲ | $1.78B ▲ | 1.88% ▲ | $1.41 ▲ | $4.56B ▲ |
| Q4-2024 | $97.71B ▲ | $10.53B ▼ | $1.64B ▲ | 1.68% ▲ | $1.31 ▲ | $4.03B ▲ |
| Q3-2024 | $95.43B | $11.73B | $87M | 0.09% | $0.07 | $2.02B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $11.29B ▼ | $255.33B ▼ | $182.22B ▲ | $72.93B ▼ |
| Q2-2025 | $14.22B ▲ | $258.34B ▲ | $180.79B ▲ | $77.38B ▲ |
| Q1-2025 | $12.65B ▲ | $255.59B ▲ | $178.47B ▲ | $76.93B ▲ |
| Q4-2024 | $10.99B ▲ | $253.22B ▲ | $177.49B ▲ | $75.56B ▲ |
| Q3-2024 | $9.68B | $252.43B | $177.32B | $74.94B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-2.8B ▼ | $796M ▼ | $-2.09B ▼ | $-1.38B ▼ | $-2.67B ▼ | $98M ▼ |
| Q2-2025 | $1.02B ▼ | $1.9B ▼ | $-1.02B ▼ | $806M ▲ | $1.68B ▲ | $1.29B ▼ |
| Q1-2025 | $1.78B ▲ | $4.56B ▲ | $-762M ▼ | $-2.33B ▼ | $1.46B ▼ | $3.81B ▲ |
| Q4-2024 | $1.62B ▲ | $1.86B ▲ | $-547M ▲ | $431M ▲ | $1.74B ▲ | $1.09B ▲ |
| Q3-2024 | $71M | $-745M | $-3.35B | $-1.59B | $-5.68B | $-1.42B |
Revenue by Products
| Product | Q4-2024 | Q3-2025 | Q1-2025 | Q2-2025 |
|---|---|---|---|---|
 Corporate And Other Segment | $0 ▲ | $0 ▲ | $0 ▲ | $100.00M ▲ |
 Front Store Revenue | $5.67Bn ▲ | $5.19Bn ▼ | $5.24Bn ▲ | $5.37Bn ▲ |
 Pharmacy Revenue | $56.24Bn ▲ | $59.55Bn ▲ | $52.51Bn ▼ | $55.35Bn ▲ |
 Premiums | $30.91Bn ▲ | $33.72Bn ▲ | $32.82Bn ▼ | $34.20Bn ▲ |
 Product and Service Other | $4.13Bn ▲ | $1.02Bn ▼ | $3.50Bn ▲ | $3.52Bn ▲ |
CEO
J. David Joyner CEBS
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2005-06-07 | Forward | 2:1 |
| 1998-06-16 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 775
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
Grade Summary
Showing Top 6 of 16
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:119.84M
Value:$9.51B
VANGUARD GROUP INC
Shares:118.89M
Value:$9.43B
BLACKROCK INC.
Shares:100.15M
Value:$7.94B
Summary
Showing Top 3 of 2,673